KRAS and cancer: (Figure 9D, Figure S11D) highlighted those related genes highly expressed in the high-risk subtype showed significant enrichment in multiple cancer-related pathways such as IL6-JAK-STAT3 signaling, Wnt-β-catenin signaling, Kras signaling and IL2-STAT5 signaling based on the TCGA cohort and Meta cohort.